Pharmababble
Biomedical investment and business development chatter
RSS Feed
Home
About
Archives
Biopharma BD
Life Sci Investing
Contact
// you’re reading...
Uncategorized
6.11.08
By
Eben Tessari
⋅
June 11, 2008
⋅
Email This Post
⋅
Print This Post
⋅
Post a comment
Share and Enjoy:
Theoretically Related Posts
No Related Post
Discussion
No comments for “6.11.08”
Post a comment
Name *
E-mail *
Web site
Comment
Categories
Clinical Trial Results
Closing Bell
Company Shakeups
FDA/Regulatory
Financial
Intellectual Property
IPO
License/Partnership
M&A
Restructurings and Layoffs
Sales/Marketing
Science
Statistics
Uncategorized
Venture Capital
Video
Recent Comments
BMS Offers to Buy The Rest of ImClone | Pharmababble
on
Bristol-Myers Squibb To Be Acquired By… [Insert Name Here]??
Wyeth and Elan in a World of Pain | Pharmababble
on
Bapineuzumab Fails Trial
Myriad Cancels Flurizan Development | Pharmababble
on
Failed Drug in Alzheimers and Prostate Cancer Gets Licensed in Europe
Big pharma links for 06-11-08 | The eDrugSearch Blog
on
Big Pharma Tries to Shake Things Up
Guide to Financial Statements: Cash Flows | Pharmababble
on
Guide to Financial Statements: Intro
Honors and Affiliations
Blogroll
business|bytes|genes|molecules
Colorado Life Science Deal Flow
Deal Lawyers
Drug Wonks
Eye on FDA
Futile Cycle
Health Business Blog
In The Pipeline
My Biotech Life
My Google Reader Feed
On Pharma
One Med Place
Orange Book Blog
Patent Baristas
Pharma Marketing Blog
Pharma’s Market
PharmaGossip
Pharmalot
The Biotech Weblog
The Health Care Blog
The In Vivo Blog
The Physician Executive
Venture Beat
WSJ Health Blog
Discussion
No comments for “6.11.08”
Post a comment